Search
Jade Biosciences Ord Shs
JBIOAdd to Watchlist
16.140USD
+0.270+1.70%
Close 11-13 16:00（ET）
1.03BMarket Cap
LossP/E TTM
JBIO Analyst Recommendation Trends
In the current month, JBIO has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. JBIO average Analyst price target in the last month is 49.889.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
6
6
6
6
6
6
6
5
5
5
5
5
4
4
4
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
10
10
10
8
Financial Forecasting
Based on analysts' estimates, JBIO EPS is projected to reach -0.729 in FY2026Q4, following reported EPS of -0.488 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.48
-0.64
-0.71
-0.73
-0.75
Actual
-0.57
-0.76
-0.49
--
--
Surprise
-18.81%
-19.01%
+31.42%
--
--
FAQs
How have Jade Biosciences Ord ShsJBIO's recent earnings per share performed?
The market expectation was USD -0.49, while Jade Biosciences Ord ShsJBIO's earnings per share (EPS) for the previous quarter was USD -0.76. EPS for the next quarter is expected at USD -0.73.
What is the analyst rating for Jade Biosciences Ord Shs?
Based on the ratings of Jade Biosciences Ord Shs's stock from 11 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.